BioStock: Prolight Diagnostics’ collaboration with G&H | ITL propels development
Prolight Diagnostics have appointed G&H | ITL for the development of its innovative point-of-care system, Psyros. The development project started in early 2023 and is steadily progressing. BioStock reached out to G&H’s CEO Charlie Peppiatt and Prolight Diagnostics’ Head of Engineering, Paul Monaghan, to gain further insight into the current status of development.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se